Shareholding disclosure
Kuros Biosciences AG
Collectively declared rate
3%
Threshold
Fell below threshold
Timeline
Published
12.09.2018
Transaction
04.09.2018
Voting rights breakdown
Declared beneficial owners · 4
A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.
Notice details
Notification ID
TBI9A00012
Beneficial owner
Frank-Jan van der Velden
Declared address
Frank-Jan van der Velden, Echteld
The conditional right to acquire new shares pursuant to a Combination Agreement entered with Kuros Biosciences AG (the Issuer ) on 18 December 2016 (the Combination Agreement ) whereas 1 365 000 shares of the Issuer were acquired at closing of the Combination Agreement and 740 000 shares of the Issuer were to be acquires on the achievement of certain product approval milestones has been exercised after full achievement of such milestones. The group of buyers has acquired all shares of the Issuer as provided in the Combination Agreement. The group shall therefore be terminated. A) Incubation B.V., Bilthoven, controlled by (i) Dagomar B.V., Echteld, the Netherlands, a company controlled by Person 1 (Frank-Jan Van der Velden) and (ii) Dr. C.A. van Blitterswijk Holding B.V., Ruigahuizen, the Netherlands, a company controlled by Person 2 (Clemens van Blitterswijk); (B) Aldabra B.V., Amersfoort, the Netherlands, a company controlled by Person 3 (Joost de Bruijn) and (C) Person 4 (Yuan Huipin) shall acquire the shares.
insider24.ch
Never miss a market signal again
Need more? Discover the Pro plan